மருத்துவ மற்றும் ஆய்வக ஆராய்ச்சியின் அன்னல்ஸ்

  • ஐ.எஸ்.எஸ்.என்: 2386-5180
  • ஜர்னல் எச்-இண்டெக்ஸ்: 17
  • ஜர்னல் மேற்கோள் மதிப்பெண்: 6.26
  • ஜர்னல் தாக்க காரணி: 5.31
குறியிடப்பட்டது
  • ஜெனமிக்ஸ் ஜர்னல்சீக்
  • சீனாவின் தேசிய அறிவு உள்கட்டமைப்பு (CNKI)
  • CiteFactor
  • டைரக்டரி ஆஃப் ரிசர்ச் ஜர்னல் இன்டெக்சிங் (DRJI)
  • பப்ளான்கள்
  • யூரோ பப்
  • கூகுள் ஸ்காலர்
  • ஷெர்பா ரோமியோ
  • ரகசிய தேடுபொறி ஆய்வகங்கள்
இந்தப் பக்கத்தைப் பகிரவும்

சுருக்கம்

Interplay between Purα and Egr-1 in the Transcriptional Regulation of Amyloid Precursor Protein Gene Expression

Juan Chai, Yongling Li, Ke Guo, Zhongfa Jia, Lin Ma, Jianguo Niu, Tao Sun, Huichen Wang and Jianqi Cui

Background: One of the pathological hallmarks of Alzheimer’s disease is the presence of fibrillary amyloid-β deposits, which result from cleavage of the amyloid precursor protein. Understanding the regulatory mechanism of the amyloid precursor protein gene expression is crucial for comprehending the genesis and development of Alzheimer’s disease. The nucleic acid binding protein, Purα, is best characterized as a transcriptional factor (TF) with affinity to singlestrand G/C-rich regions. In a previous study, we demonstrated that the Purα protein can downregulate amyloid precursor protein (APP) promoter activity, but the mechanism underlying this downregulation requires further investigation. To better understand this mechanism, we analyzed the characteristic of the APP promoter and found that another transcriptional factor, namely Egr-1, can bind the APP promoter and may exert transcriptional regulatory effects on APP gene expression. Therefore, the interaction between these two transcriptional factors may explain the mechanism in regulating APP gene expression.

Methodology/Principal Findings: The binding sites of Purα and Egr-1 on the APP promoter 5’-UTR were identified, and reporter plasmids in which the binding sites for Purα and Egr-1 were deleted have been constructed. A luciferase assay was performed, and the results demonstrated that both Purα and Egr-1 lost their regulatory effects when these binding sites were deleted. The luciferase results also demonstrated that Purα can suppress the effects of Egr-1 on APP promoter activities. The electrophoresis mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) assay results demonstrated that both Purα and Egr- 1 can competently bind to the APP promoter. The endogenous Egr-1 expression was disturbed with the HDAC inhibitor and suramin, and the Egr-1 expression level affected the APP promoter activities and APP gene expression. Purα can also suppress the endogenous expression of Egr-1.

Conclusion/Significance: The mechanism through which Purα regulates AβPP gene expression may involve its interaction with Egr-1, which is a positive regulator of the APP promoter. Because both transcriptional factors possess the binding sites in the APP promoter 5’-UTR and the position of these sites are overlapped, there may exist a displacement mechanism for these two transcriptional factors. In addition, Purα also suppresses the endogenous Egr-1 expression. All of these findings explain the mechanism through which Purα regulates APP gene expression.

மறுப்பு: இந்த சுருக்கமானது செயற்கை நுண்ணறிவு கருவிகளைப் பயன்படுத்தி மொழிபெயர்க்கப்பட்டது மற்றும் இன்னும் மதிப்பாய்வு செய்யப்படவில்லை அல்லது சரிபார்க்கப்படவில்லை